The transcriptomics market is witnessing remarkable growth, driven by an increasing understanding of gene expression and its implications for health and disease. Currently valued at USD 7.73 billion, the market is projected to reach approximately USD 16.03 billion by 2035, reflecting a robust compound annual growth rate (CAGR) of 6.85%. This growth is emblematic of a broader shift in the...

In the current landscape of 2026, the transition to high-precision molecular diagnostics has necessitated a more rigorous approach to laboratory risk management. As part of the Transcriptomics Market Global Outlook, the integration of single-cell RNA sequencing (scRNA-seq) into clinical trials has made it mandatory for labs to move beyond basic quality checks. Risk management now involves a...

Spatial Genomics and Transcriptomics Market: Revolutionizing Precision Medicine Through Spatial Biology Market Overview The Spatial Genomics and Transcriptomics Market is rapidly emerging as one of the most innovative segments within the life sciences industry. Spatial genomics and transcriptomics technologies enable researchers to analyze gene expression and genomic information while...

  Global Spatial Transcriptomics Market Projected to Reach USD 1,487.62 Million by 2034, Driven by a 14.71% CAGR, Reports Polaris Market Research The global Spatial Transcriptomics Market has emerged as a transformative force in life sciences research, enabling scientists to measure gene expression within intact tissue architecture at unprecedented resolutions. Valued at USD 495.23...

The RNA analysis market is entering a strong growth phase as transcriptomic research, precision medicine, drug discovery, and RNA-based therapeutics increase demand for advanced molecular analysis. The market was valued at USD 9.2 billion in 2025 and is projected to grow from USD 9.9 billion in 2026 to USD 23.6 billion by 2033, registering a 13.3% CAGR from 2026 to 2033. The expansion reflects...